177.39
price down icon1.10%   -1.97
pre-market  Vorhandelsmarkt:  176.50   -0.89   -0.50%
loading
Schlusskurs vom Vortag:
$179.36
Offen:
$178.99
24-Stunden-Volumen:
1.58M
Relative Volume:
1.18
Marktkapitalisierung:
$31.62B
Einnahmen:
$15.41B
Nettoeinkommen (Verlust:
$1.37B
KGV:
23.65
EPS:
7.5
Netto-Cashflow:
$2.11B
1W Leistung:
-4.57%
1M Leistung:
-4.88%
6M Leistung:
-24.45%
1J Leistung:
-29.85%
1-Tages-Spanne:
Value
$176.03
$178.99
1-Wochen-Bereich:
Value
$176.03
$188.38
52-Wochen-Spanne:
Value
$176.03
$253.84

Iqvia Holdings Inc Stock (IQV) Company Profile

Name
Firmenname
Iqvia Holdings Inc
Name
Telefon
919-998-2000
Name
Adresse
2400 ELLIS ROAD, DURHAM, NC
Name
Mitarbeiter
0
Name
Twitter
@IQVIA_global
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
IQV's Discussions on Twitter

Vergleichen Sie IQV mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
177.39 31.62B 15.41B 1.37B 2.11B 7.50
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
500.16 196.14B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
205.85 150.17B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
415.87 34.36B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
116.69 33.28B 6.53B 1.26B 1.31B 4.35

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-03 Herabstufung BTIG Research Buy → Neutral
2024-12-20 Eingeleitet Stephens Overweight
2024-10-14 Eingeleitet Redburn Atlantic Buy
2024-09-04 Eingeleitet RBC Capital Mkts Outperform
2024-07-24 Herabstufung Jefferies Buy → Hold
2024-06-06 Eingeleitet Goldman Buy
2024-02-26 Eingeleitet Leerink Partners Outperform
2024-02-15 Herabstufung Guggenheim Buy → Neutral
2024-02-13 Eingeleitet BTIG Research Buy
2023-11-02 Herabstufung Robert W. Baird Outperform → Neutral
2023-09-06 Eingeleitet HSBC Securities Buy
2023-03-17 Eingeleitet Truist Buy
2022-12-06 Eingeleitet Cowen Outperform
2022-11-17 Herabstufung Citigroup Buy → Neutral
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-07-15 Eingeleitet SVB Leerink Outperform
2022-05-24 Eingeleitet Guggenheim Buy
2022-04-29 Hochstufung Piper Sandler Neutral → Overweight
2022-04-25 Herabstufung Wells Fargo Overweight → Equal Weight
2021-08-05 Fortgesetzt Credit Suisse Outperform
2021-04-16 Hochstufung Stephens Equal-Weight → Overweight
2021-03-08 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2021-03-03 Eingeleitet Barclays Overweight
2020-07-07 Eingeleitet Stephens Equal-Weight
2020-03-02 Eingeleitet Deutsche Bank Buy
2020-01-08 Eingeleitet Wells Fargo Overweight
2020-01-07 Eingeleitet Citigroup Buy
2019-12-13 Hochstufung CFRA Sell → Hold
2019-11-14 Hochstufung Wolfe Research Peer Perform → Outperform
2019-06-21 Hochstufung Mizuho Neutral → Buy
2019-05-28 Eingeleitet SVB Leerink Outperform
2019-01-18 Hochstufung Jefferies Hold → Buy
2018-10-09 Eingeleitet UBS Buy
2018-10-02 Bestätigt Robert W. Baird Outperform
2018-07-25 Hochstufung BofA/Merrill Neutral → Buy
2018-07-25 Bestätigt Stifel Buy
2018-07-03 Hochstufung Raymond James Outperform → Strong Buy
2018-04-13 Hochstufung Goldman Neutral → Buy
2018-03-07 Hochstufung SunTrust Hold → Buy
2018-01-19 Eingeleitet Evercore ISI Outperform
Alle ansehen

Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten

pulisher
Mar 28, 2025

Truist Financial Remains a Buy on IQVIA Holdings (IQV) - The Globe and Mail

Mar 28, 2025
pulisher
Mar 26, 2025

IQV stock touches 52-week low at $179.23 amid market challenges - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Here's Why Investors Must Hold IQV Stock in Their Portfolios Now - Yahoo Finance

Mar 26, 2025
pulisher
Mar 26, 2025

What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing? - Yahoo Finance

Mar 26, 2025
pulisher
Mar 26, 2025

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance

Mar 26, 2025
pulisher
Mar 26, 2025

IQVIA Holdings (IQV): Company Profile, Stock Price, News, Rankings - Fortune

Mar 26, 2025
pulisher
Mar 24, 2025

Why IQVIA Holdings Inc. (IQV) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey

Mar 24, 2025
pulisher
Mar 22, 2025

Boasting A 23% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock? - Yahoo Finance

Mar 22, 2025
pulisher
Mar 21, 2025

Long Term Trading Analysis for (IQV) - Stock Traders Daily

Mar 21, 2025
pulisher
Mar 21, 2025

IQVIA Holdings (IQV) Fell on Lowered Guidance - MSN

Mar 21, 2025
pulisher
Mar 19, 2025

3 Reasons IQV is Risky and 1 Stock to Buy Instead - Yahoo Finance

Mar 19, 2025
pulisher
Mar 18, 2025

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 100% Above Its Share Price - Yahoo Finance

Mar 18, 2025
pulisher
Mar 16, 2025

Sequoia Financial Advisors LLC Grows Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Mar 16, 2025
pulisher
Mar 14, 2025

Mizuho Adjusts Price Target on IQVIA Holdings to $242 From $247, Maintains Outperform Rating - Marketscreener.com

Mar 14, 2025
pulisher
Mar 13, 2025

Is IQVIA Holdings Stock Underperforming the Dow? - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Jones Financial Companies Lllp Buys 441 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Victory Capital Management Inc. Sells 9,038 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

IQVIA (NYSE:IQV) Downgraded to “Hold” Rating by StockNews.com - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Argus Adjusts IQVIA Holdings Price Target to $245 From $260, Maintains Buy Rating -March 11, 2025 at 09:47 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

SBI Securities Co. Ltd. Acquires New Holdings in IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

(IQV) Investment Report - Stock Traders Daily

Mar 11, 2025
pulisher
Mar 10, 2025

IQVIA Holdings Refinances Debt, Lowers Interest Rate By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

IQVIA Holdings Refinances Debt, Lowers Interest Rate - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services - StockTitan

Mar 10, 2025
pulisher
Mar 08, 2025

StockNews.com Upgrades IQVIA (NYSE:IQV) to "Buy" - MarketBeat

Mar 08, 2025
pulisher
Mar 07, 2025

IQVIA Gains From Diversified Client Base Despite Low Liquidity Woes - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

M&T Bank Corp Trims Stake in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Mar 07, 2025
pulisher
Mar 06, 2025

At US$186, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List? - Simply Wall St

Mar 06, 2025
pulisher
Mar 06, 2025

IQVIA at TD Cowen Conference: Strategic Insights and Growth Outlook - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Citigroup Issues Pessimistic Forecast for IQVIA (NYSE:IQV) Stock Price - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

IQVIA (NYSE:IQV) Upgraded to Buy at StockNews.com - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

IQVIA (NYSE:IQV) Reaches New 52-Week Low Following Analyst Downgrade - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Iqvia Laboratories Launches Site Lab Navigator With Breakthrough E-Requisition Innovation To Transform Clinical Trials - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings grew faster than the favorable 8.3% CAGR delivered to IQVIA Holdings (NYSE:IQV) shareholders over the last five years - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Citigroup Adjusts Price Target on IQVIA Holdings to $210 From $225, Maintains Neutral Rating - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

How IQVIA's New E-Requisition Technology Could Eliminate Major Clinical Trial Bottlenecks - StockTitan

Mar 04, 2025
pulisher
Mar 01, 2025

Zacks Research Issues Optimistic Outlook for IQVIA Earnings - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Brokers Offer Predictions for IQVIA's Q1 Earnings (NYSE:IQV) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Tower Bridge Advisors - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Bruni J V & Co. Co. Acquires New Stake in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Proficio Capital Partners LLC Buys Shares of 148,040 IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Atria Wealth Solutions Inc. Sells 831 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Stack Financial Management Inc Sells 2,198 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Heritage Investors Management Corp Raises Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

IQVIA Holdings Inc. (NYSE:IQV) Stock Position Lowered by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Pine Valley Investments Ltd Liability Co Boosts Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

IQVIA Holdings Inc. stock rises Friday, still underperforms market - MarketWatch

Feb 28, 2025
pulisher
Feb 28, 2025

IQVIA (NYSE:IQV) Hits New 1-Year LowShould You Sell? - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Zacks Research Issues Optimistic Forecast for IQVIA Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Versor Investments LP Grows Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Feb 28, 2025

Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research A
$116.69
price down icon 1.92%
$415.87
price down icon 1.58%
diagnostics_research MTD
$1,177.09
price down icon 1.36%
diagnostics_research WAT
$362.16
price down icon 2.27%
$143.94
price down icon 2.94%
Kapitalisierung:     |  Volumen (24h):